Agenda - Council Work Session - 04/11/2023

Home

HF100 NINTH ENGROSSMENT REVISOR BD 1-10100-9 23.1 voluntarily agreed to accept mental health or substance use treatment or admission to a 23.2 state -operated treatment program or treatment facility. The report must include summary 23.3 data disaggregated by the month of admission or order; age, race, and sex of the individuals; 23.4 whether the admission or order was for a mental illness or substance use disorder; and, to 23.5 the extent known, the substance of abuse that resulted in the admission or order. Data must 23.6 be obtained, retained, and reported in a way that prevents the unauthorized release of private 23.7 data on individuals as defined in section 13.02. The office shall submit the report by January 23.8 15. 2027. and the report may be combined with the annual report submitted by the office. 23.9 (f) The office shall conduct an annual market analysis on the status of the regulated 23.10 cannabis industry and submit a report of the findings. The office shall submit the report by 23.11 January 15 of each year and the report may be combined with the annual report submitted 23.12 by the office. The process of completing the market analysis must include holding public 23.13 meetings to solicit the input of consumers, market stakeholders, and potential new applicants 23.14 and must include an assessment as to whether the office has issued the necessary number 23.15 of licenses in order to: 23.16 (1) ensure the sufficient supply of cannabis flower and cannabis products to meet demand; 23.17 (2) provide market stability; 23.18 (3) ensure a competitive market; and 23.19 (4) limit the sale of unregulated cannabis flower and cannabis Droducts. 23.20 (g) The office shall submit an annual report to the legislature by January 15, 2024, and 23.21 each January 15 thereafter. The annual report shall include but not be limited to the following: 23.22 (1) the status of the regulated cannabis industry; 23.23 (2) the status of the illicit cannabis market; 23.24 (3) the number of accidents, arrests, and convictions involving drivers who admitted to 23.25 using cannabis flower, cannabis products, lower -potency hemp products, or hemp -derived 23.26 consumer products, or who tested positive for cannabis or tetrahydrocannabinol; 23.27 (4) the change in potency, if any, of cannabis flower and cannabis products available 23.28 through the regulated market; 23.29 (5) progress on providing opportunities to individuals and communities that experienced 23.3o a disproportionate, negative impact from cannabis prohibition, including but not limited to 23.31 providing relief from criminal convictions and increasing economic opportunities; 23.32 (6) the status of racial and geographic diversity in the cannabis industry; Article 1 Sec. 4. 23